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he molecular mechanisms underlying early/recycling
endosomes-to-TGN transport are still not understood.
We identiﬁed interactions between the TGN-localized
putative t-SNAREs syntaxin 6, syntaxin 16, and Vti1a, and two
early/recycling endosomal v-SNAREs, VAMP3/cellubrevin,
and VAMP4. Using a novel permeabilized cell system,
these proteins were functionally implicated in the post-Golgi
retrograde transport step. The function of Rab6a’ was also
required, whereas its closely related isoform, Rab6a, has
T
 
previously been implicated in Golgi-to-endoplasmic re-
ticulum transport. Thus, our study shows that membrane
exchange between the early endocytic and the biosynthetic/
secretory pathways involves speciﬁc components of the
Rab and SNARE machinery, and suggests that retrograde
transport between early/recycling endosomes and the endo-
plasmic reticulum is critically dependent on the sequential
action of two members of the Rab6 subfamily.
 
Introduction
 
The existence of two connecting routes between the endocytic
and the biosynthetic/secretory pathway has been suggested
(Rohn et al., 2000). The first one is linking late endosomes
and the trans-Golgi network (TGN)*. A series of studies
revealed the molecular mechanisms driving mannose 6-phos-
phate receptor retrieval to the TGN via this pathway. It is reg-
ulated by the small GTPase Rab9 and its effector p40
 
(Lombardi et al., 1993) and facilitated by 
 
 
 
-SNAP, a compo-
nent of the SNARE machinery (Itin et al., 1997). The recently
identified protein TIP47 interacts with the cytosolic domain
of mannose 6-phosphate receptors, and is also implicated in
late endosomes-to-TGN trafficking (Carroll et al., 2001).
Morphological and biochemical evidence indicates that
the receptor-binding, nontoxic B-subunit of Shiga toxin
(STxB) traffics via an alternative pathway directly from the
early endosome (EE) to the TGN, bypassing the late en-
docytic pathway (Mallard et al., 1998). This newly described
pathway may also involve the recycling endosome (RE) and
the GTPase Rab11 (Wilcke et al., 2000). Similar observa-
tions were made studying TGN38, a cellular protein known
to recycle between the TGN and the plasma membrane
(Ghosh et al., 1998). The molecular mechanisms underlying
EE/RE-to-TGN transport are still largely unexplored. Our
observation that internalized STxB colocalized with 
 
 
 
-adaptin
and clathrin on EE/RE implied that AP1/clathrin coats
might regulate membrane dynamics at the EE/RE-TGN
interface (Mallard et al., 1998). Based on functional studies,
a role for AP1 and the AP1 interactor PACS-1 was revealed
in retrograde transport to the TGN of furin and MPR
(Meyer et al., 2000; Crump et al., 2001; Fölsch et al., 2001),
suggesting that these molecules may at least in part also use
the EE/RE-to-TGN pathway. Importantly, this direct path-
way may allow signaling molecules such as CD19 (Khine et
al., 1998), interferon 
 
 
 
/
 
 
 
 receptors (Khine and Lingwood,
2000), or GPI-anchored receptors, e.g., CD14 (Thieblemont
and Wright, 1999), to escape the degradative environment
of late endosomes to reach internal sites where they may
interact with their intracellular targets.
Another group of proteins with key functions in membrane
transport are small N-ethylmaleimide (NEM)-sensitive fu-
sion factor (NSF) attachment protein (SNAP) receptors
(SNAREs) (Rothman and Wieland, 1996; Hay and Scheller,
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1997; Johannes and Galli, 1998). These tail-anchored mole-
cules are located on specific membranes inside the cell where
they form stable complexes that can be dissociated by the
ATPase NSF/SNAP (Söllner et al., 1993). The current
model suggests that t-SNAREs on target membranes, and
v-SNAREs on transport vesicles cooperate with other proteins
to form trans-complexes that bring vesicle- and target-mem-
branes in close proximity to promote membrane fusion
(Weber et al., 1998). However, the details of the fusion reac-
tion and the exact role of the SNAREs remain to be estab-
lished (Mayer, 1999). After fusion, the cis-SNARE com-
plexes are dissociated by NSF/SNAP activity and SNAREs
can reenter a new functional cycle.
Here, we identified the central elements of the molecular
machinery of post-Golgi retrograde transport, thus establish-
ing, by functional means, the existence of a regulated and ef-
ficient transport connection between the early endocytic
pathway and the TGN.
 
Results
 
A novel experimental system to measure STxB 
transport from EE/RE to the TGN
 
In the absence of a molecular understanding of membrane
dynamics at the interface between the endocytic and the bio-
synthetic/secretory pathways, the existence of EE/RE-to-
TGN transport has remained controversial. We have there-
fore reconstituted transport of STxB from EE/RE to the
TGN in streptolysin O (SLO)-permeabilized HeLa cells. A
previously constructed recombinant modified STxB with
two COOH-terminal sulfation sites, termed STxB-Sulf
 
2
 
,
was chosen as a reporter molecule because its sulfation by
TGN-localized sulfotransferase allows detection and quanti-
fication of arrival in the TGN (Mallard et al., 1998). STxB-
Sulf
 
2
 
 was accumulated in EE/RE of intact HeLa cells by
continuous incubation at low temperatures (Mallard et al.,
1998) (Fig. 1 A, main protocol). The cells were then sub-
jected to SLO permeabilization, and transport to the TGN
Figure 1. Characterization of the experimental permeabilized cell system. (A) Generic protocols used to reconstitute STxB transport from 
the EE to the TGN. (Perm.) Permeabilization in the absence of exogenous cytosol. (Inset) Variations 1 and 2 were used to compare transport 
efficiencies in intact or permeabilized HeLa cells (means of two experiments). (Detection) Incubation of permeabilized cells with [
35S]sulfate 
and ATP-regenerating system (ATP reg. sys.) in the absence of cytosol. (B and C) STxB transport to the TGN depends on the presence of 
cytosol in a dose-dependent manner. A representative gel is shown in B, and the corresponding quantification in C. Means of two [
35S]-PAPS 
(PAPS) or three [
35S]sulfate (
35SO4
2-) experiments (  SEM). Note that similar responses are observed when [
35S]sulfate or [
35S]-PAPS are used 
as sulfuryl donors (the total amounts of sulfated STxB-Sulf2 obtained in both conditions are comparable). (D) Sulfation as such is not cytosol 
dependent. STxB-Sulf2 was preaccumulated, either in the Golgi apparatus at 37 C, or in the EE at 19.5 C before permeabilization and incubated 
with or without cytosol. (E) STxB transport to the TGN is ATP dependent. As in D, STxB-Sulf2 was accumulated in the EE or the Golgi apparatus 
before permeabilization and incubation with complete or ATP-depleted cytosol in the presence of 
35S-PAPS to render the sulfation reaction as 
such ATP independent. (F) Kinetics of STxB transport to the TGN. Permeabilized cells were continuously incubated with [
35S]sulfate for the 
indicated times. (G and H) STxB transport to the TGN in permeabilized cells detected by electron microscopy. STxB was internalized into the 
EE, and the cells were permeabilized and then incubated for 30 min at 37 C before fixation and cryosectioning. Cryosections were labeled for 
STxB (15-nm gold particles) and (G) TGN46 (10-nm gold particles) or (H) GalT (10-nm gold particles). Bars, 100 nm. 
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was assayed in the presence of [
 
35
 
S]sulfate (Fig. 1 B). The
SLO permeabilization technique was particularly adapted to
our studies because only the plasma membrane is permeabi-
lized following binding of SLO to cells on ice.
In the absence of exogenous cytosol, transport was 19%
(
 
 
 
 5.8%, 
 
n 
 
  
 
55) of that detected in the presence of 3 mg/
ml of cytosol (Fig. 1, B, C, and D, condition EE). The sulfa-
tion reaction per se was not dependent on exogenous cytosol
because STxB-Sulf
 
2
 
, preaccumulated in the Golgi apparatus
of intact cells (Fig. 1 D, Golgi), was sulfated, after permeabi-
lization, in the same manner in the presence or absence of
exogenous cytosol. In addition, the same dose-dependence
on exogenous cytosol was observed when [
 
35
 
S]-labeled 3
 
 
 
-
phosphoadenosine 5
 
 
 
-phosphosulfate (PAPS) instead of
[
 
35
 
S]sulfate was used as a direct sulfuryl donor (Fig. 1 C).
To determine whether STxB transport to the TGN was
energy dependent, we examined both complete and ATP-
depleted cytosol (Fig. 1 E). These experiments were done
with [
 
35
 
S]-labeled PAPS to render the sulfation reaction it-
self ATP independent. Under these conditions, TGN-local-
ized STxB-Sulf
 
2
 
 was still efficiently sulfated, independent of
the addition of an ATP regeneration system (Fig. 1 E Golgi,
black bars). However, STxB transport to the TGN from the
EE was strongly inhibited in the absence of ATP (Fig. 1 E,
EE, white bars).
STxB-Sulf
 
2
 
 was transported to the TGN with comparable
kinetics in permeabilized and intact cells. In fact, maximal
sulfation was reached after 45 min in permeabilized cells
(Fig. 1 F), as in intact cells (Mallard et al., 1998). Further-
more, we found that the efficiency of transport in permeabi-
lized cells was 25% of that in intact cells (Fig. 1 A, insert),
comparable to other in vitro systems that reconstitute cou-
pled budding and fusion reactions. Throughout this manu-
script, this percentage was set to 100% for comparison pur-
poses. Finally, electron microscopical studies established that
in SLO-permeabilized cells, a significant part of internalized
STxB (Fig. 1, G–H, 15 nm) gained access to structures la-
beled by the TGN markers TGN46 (Fig. 1 G, 10-nm gold
particles, arrows) and galactosyl-transferase (Fig. 1 H, 10-
nm particles, arrows), as previously described in intact cells
(Johannes et al., 1997; Mallard et al., 1998). Morphologi-
cally identifiable Golgi stacks were also marked under these
conditions (Fig. 1 H). In the absence of cytosol, no STxB
transport to the Golgi could be detected (unpublished data).
Taken together, these results show that STxB transport
from EE/RE to the TGN was efficiently reconstituted in
SLO-permeabilized cells. The process exhibited the hall-
marks characteristics of in vivo transport, and revealed ca-
nonical biochemical requirements observed for other in vitro
reconstituted transport steps.
 
t-SNARE proteins in EE/RE-to-TGN transport
 
SNAREs are key regulators of vesicular membrane traffic.
To test whether EE/RE-to-TGN transport was SNARE de-
pendent, SNARE activity was inhibited using the dominant-
negative 
 
 
 
-SNAP mutant L294A that is unable to stimulate
the ATPase activity of NSF (Barnard et al., 1997). When
added to permeabilized cells, recombinant 
 
 
 
-SNAP(L294A)
inhibited STxB transport in a dose-dependent manner (Fig.
2 A). Transport could also be slightly stimulated by the ad-
dition of low concentrations of wild-type 
 
 
 
-SNAP (Fig. 2
A). These data strongly indicated a role for SNARE proteins
in EE/RE-to-TGN transport.
We then set out to use the permeabilized cell system to
identify the t-SNAREs that would function in the fusion
process involving EE/RE-derived STxB-containing trans-
port intermediates. Syn6, Syn10, Syn16, and Vti1a were
chosen for our studies because of their localization in the
Golgi apparatus (Bock et al., 1997; Simonsen et al., 1998;
Tang et al., 1998a, 1998b; Xu et al., 1998), and Syn7 as a
negative control for its exclusive localization on endosomes
(Nakamura et al., 2000). Syn16 appeared of particular inter-
est because of its extensive colocalization with the trans-
Golgi marker TGN38 (Fig. 2 D, top panel), which persisted
upon BFA treatment (Fig. 2 D, bottom panel). As shown in
Fig. 2 B, antibodies against Syn6, Syn16, and Vti1a potently
inhibited transport, while anti-Syn7, anti-Syn10, or an irrel-
evant rabbit control IgG mixture had no significant effect.
The use of anti-Syn16 at higher doses did not significantly
increase inhibition (Fig. 2 C, Syn16[200]), indicating that
either the antibody itself was only partially inhibitory, or
that Syn16 containing complexes are not the only ones con-
trolling STxB transport to the TGN. Prebinding of anti-
Syn16 to recombinant His-tagged Syn16 completely abol-
ished the inhibitory effect of the antibody (Fig. 2 C). The
anti-Syn16 effect was not due to cross-linking of Syn16 on
target membranes, since monovalent Fab fragments gener-
ated from the antibody also potently inhibited transport
(Fig. 2 C). Prebinding of Fab fragments to His-tagged Syn16
resulted in the loss of inhibition (Fig. 2 C). Taken together,
these results suggest that Syn16, Syn6, and Vti1a participate
in STxB transport to the TGN.
Interestingly, we observed that the inhibitory effects of
anti-Syn6 and anti-Syn16 antibodies were not additive (Fig.
2 E), indicating that their respective target molecules func-
tion in the same transport pathway, possibly within the same
molecular complex. The latter indication was tested by
coimmunoprecipitation. Syn16 was immunoprecipitated
from Triton X-100 lysates of HeLa cells. The precipitate was
then probed by immunoblot for the presence of a cis-Golgi
SNARE, Syn5 (Dascher et al., 1994; Rowe et al., 1998), the
Golgi/TGN and endosomal SNAREs Syn6, Vti1a, and
Vti1b (Bock et al., 1997; Advani et al., 1998; Xu et al.,
1998), and the endosomal SNAREs Syn7 and Syn12 (Tang
et al., 1998c; Nakamura et al., 2000). Syn6 was coimmuno-
precipitated with Syn16 (Fig. 2 F), confirming their physical
association. Vti1a was also found in the Syn16 immunopre-
cipitate (Fig. 2 F), an observation that is consistent with the
inhibitory effect of the anti-Vti1a antibody on transport to
the TGN (Fig. 2 B). In a separate experiment, both Vti1a
and Syn16 were also coimmunoprecipitated with Syn6 (un-
published data).
We used an overexpression approach to further confirm
the role of Syn6 and Syn16 in retrograde transport to the
TGN in intact cells. Previous studies had indicated that the
cellular TGN marker protein TGN38, like STxB, cycles
from EE/RE to the TGN (Ghosh et al., 1998; Mallard et al.,
1998). As syntaxins are tail-anchored proteins with a major-
ity of the polypeptide exposed to the cytosol, the cytosolic
domains (cyto) of these molecules are expected to function 
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as dominant negative mutants. We therefore tested whether
expression of Syn6-cyto and Syn16-cyto would have an ef-
fect on the trafficking of TGN38 in CHO cells stably ex-
pressing a Tac epitope–tagged version of the protein (Ghosh
et al., 1998). In most untransfected cells or cells expressing
Syn7-cyto, anti-Tac antibody, added from the outside of the
cell, was found to accumulate in the perinuclear Golgi area
(Fig. 2 G). In contrast, 
 
 
 
50% of cells expressing Syn16-cyto
or Syn6-cyto did not display Golgi-accumulation (Fig. 2 G),
indicating that the soluble cytosolic domains of Syn6 and
Syn16 blocked TGN38 transport to the TGN. Similar re-
sults were obtained when STxB EE/RE-to-TGN transport
was followed in cytosolic domain expressing cells (unpub-
lished data). In conclusion, the same Golgi/TGN-localized
t-SNAREs appeared to regulate the retrograde transport of
two markers, STxB and TGN38, to the TGN.
 
Identification of v-SNAREs in EE-to-TGN transport
 
A SNARE-mediated EE/RE-to-TGN transport model
would implicate an interaction between the TGN-localized
Syn6/Syn16/Vti1a t-SNAREs and putative early endosomal
v-SNAREs. Therefore, anti-Syn6 or anti-Syn16 immuno-
precipitates were analyzed for the presence of four VAMP
family proteins known to be localized to endosomes:
VAMP3/cellubrevin (McMahon et al., 1993; Galli et al.,
1994), VAMP4 (Steegmaier et al., 1999), VAMP7/TI-
VAMP (Galli et al., 1998), and VAMP8/endobrevin (Wong
et al., 1998). Intact cells were treated before lysis either with
Figure 2. Retrograde transport to the 
TGN is mediated by the t-SNAREs Syn6, 
Syn16, and Vti1a. An experimental 
protocol as shown in Fig. 1 A was used. 
(A) STxB-Sulf2 transport to the TGN was 
assayed by sulfation analysis in the 
presence of the indicated concentrations 
of recombinant wild- type  -SNAP (wt) 
or a dominant negative  -SNAP mutant 
(L294A). As in the following parts of the 
figure, means (  SEM) of two to six 
experiments are shown. (B) 25–50  g/ml 
of anti-Syn6, 7, 10, 16, or anti-Vti1a 
antibodies were continuously present 
from permeabilization on. Rb IgG, rabbit 
control IgG. The experiments with Syn6 
were performed both with a monoclonal 
and a polyclonal antibody. (C) Anti-Syn16 
antibody and Fab fragments generated 
from this antibody (Syn16[Fab]) had 
comparable inhibitory effects on 
STxB-Sulf2 transport to the TGN. 
Inhibition could be reversed by prebind-
ing of the antibodies to recombinant 
His-tagged Syn16. Higher doses of anti-
Syn16 (200  g/ml; Syn16[200]) did not 
significantly increase the inhibitory 
effect. (D) Syn16 localization in the 
TGN. Note that upon BFA treatment, 
the perinuclear staining of TGN38 and 
Syn16 collapsed into a microtubule 
organizing center-like staining, a charac-
teristic of TGN proteins. (E) Antibodies 
against Syn6 and Syn16 had no additive 
inhibitory effects on STxB-Sulf2 trans-
port to the TGN, suggesting that both 
proteins function in the same molecular 
complex. (F) Antibody against Syn16 
coimmunoprecipitated Syn6 and Vti1a, 
but not Vti1b, the cis-Golgi Syn5 or the 
endosomal Syn7 or Syn12. (G) Expression 
of Syn6-cyto and Syn16-cyto, but not of 
Syn7-cyto in Tac-TGN38–transfected 
CHO cells, specifically inhibited trans-
port of internalized anti-Tac antibodies 
to the TGN. 
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NEM to accumulate cognate SNARE complexes, or with
DTT-inactivated NEM as a control. An increase of SNARE
complex recovery after NEM treatment indicates that the
complexes did not form after lysis and dilution (Galli et al.,
1998). VAMP3/cellubrevin, VAMP4, and VAMP8/endo-
brevin coimmunoprecipitated with Syn6 (Fig. 3 A). Of
these, only VAMP4, and to a lesser extent VAMP3/cellubre-
vin coimmunoprecipitated with Syn16 (Fig. 3 B). Associa-
tion of VAMP3/cellubrevin and VAMP4 with Syn6 and
Syn16 implied that they were candidate v-SNAREs for the
regulation of EE-to-TGN transport.
Antibodies to VAMP4 or VAMP3/cellubrevin also coim-
munoprecipitated Syn6 and Vti1a (Fig. 3, C–D). Again,
VAMP4 was more efficient than VAMP3/cellubrevin, sug-
gesting that VAMP4 may be more important for retrograde
transport at the EE/RE-TGN-interface than VAMP3/cellu-
brevin. Syn16 was clearly detected in the anti-VAMP4 immu-
noprecipitate (Fig. 3 C), whereas a smear from the heavy
chain prohibited its detection in the anti-VAMP3/cellubrevin
immunoprecipitate (unpublished data). A small amount of
Vti1b could be found in the anti-VAMP4 immunoprecipitate
(Fig. 3 C), much less than for Vti1a. Importantly, antibody to
VAMP4 did not coimmunoprecipitate VAMP3/cellubrevin,
and vice versa (Fig. 3, C–D). This observation suggests that
both v-SNAREs, VAMP4 and VAMP3/cellubrevin, inter-
acted independently with the same t-SNAREs.
Figure 3. Identification of v-SNAREs in 
STxB transport from the EE to the TGN. 
Cells were treated either with NEM, or 
NEM quenched with DTT (NEM/DTT) 
before lysis in immunoprecipitation 
buffer. IP, immunoprecipitation. (A) 
VAMP3/cellubrevin, VAMP4, and 
VAMP8/endobrevin were coimmuno-
precipitated with Syn6, but not VAMP7/
TI-VAMP. (B) Among the VAMPs that 
interacted with Syn6, only VAMP3/
cellubrevin and VAMP4 were also 
coimmunoprecipitated with Syn16. (C) 
Antibodies to VAMP4 coimmunoprecip-
itated Syn6, Syn16, and Vti1a, and 
immunoprecipitated VAMP4 itself. Vti1b 
could also be detected, but to a much 
lesser extent than Vti1a. (D) Antibodies 
to VAMP3/cellubrevin immunoprecipi-
tated VAMP3/cellubrevin itself, and 
coimmunoprecipitated Syn6 and Vti1a, 
but not Vti1b. The presence of Syn16 
on blots could not be resolved due to 
its close proximity to the heavy chains 
of anti-VAMP3/cellubrevin antibody 
used for the immunoprecipitation. 
Note that anti-VAMP4 did not coimmu-
noprecipitate VAMP3/cellubrevin (C), 
and vice versa (D). 
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Figure 4. Functional implication of VAMP4 in 
EE-to-TGN transport. An experimental protocol 
as shown in Fig. 1 A was used. (A) Permeabilized 
HeLa cells were incubated in the continuous
presence of 0.1 or 0.4 mg/ml of anti-VAMP4 anti-
body, 0.4 mg/ml of control Rb IgG, or 0.25 mg/ml 
recombinant cytosolic fragments of VAMP4 
(VAMP4-cyto) or VAMP8 (VAMP8-cyto). STxB-Sulf2 
transport from EE/RE to the TGN was sampled by 
sulfation analysis. The inhibitory anti-VAMP4 
effect was reversed by prebinding of the antibody 
to its peptide antigen. Peptide antigen alone had 
no effect on transport (unpublished data). Means of 
three to seven experiments (  SEM) are shown. (B) 
Expression of VAMP4-cyto inhibited anti-Tac anti-
body transport to the TGN in CHO cells expressing 
Tac-TGN38, whereas expression of VAMP7-cyto 
had no effect. (C) Antibodies against VAMP4 
and Syn16 had no additive inhibitory effects on 
STxB-Sulf2 transport from EE/RE to the TGN, 
suggesting that both molecules function within 
the same molecular complex. One experiment 
representative of two is shown.
Figure 5. Putative role of VAMP3/cel-
lubrevin in EE/RE-to-TGN transport. (A) 
TeNT was added at the indicated doses 
to SLO-permeabilized HeLa cells. 
Lysates from these cells were blotted 
for the indicated v-SNAREs. Note that 
among the tested proteins, only VAMP3/
cellubrevin was cleaved. (B) TeNT-
treated and control HeLa cell extracts 
were probed with an antibody (10.1) 
which recognizes the synaptobrevin-like 
members of the VAMP family. (Arrow) 
Migration of VAMP3/cellubrevin on a 
parallel blot. (C) The incubation of 
permeabilized cells with TeNT led to a 
partial inhibition of STxB-Sulf2 transport 
to the TGN, whereas the TeNT mutant 
E234Q was without effect. (D) When 
anti-VAMP4 antibody and TeNT were 
used in the same reactions, additive
inhibition of STxB-Sulf2 transport was 
observed, suggesting that VAMP4 and 
the TeNT targets function in different 
molecular complexes or in parallel 
pathways. In C and D, an experimental 
protocol as shown in Fig. 1 A was used. 
Means of three to nine experiments 
(  SEM) are shown. 
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To study the function of VAMP4, an antibody was made
against a peptide from the NH
 
2
 
 terminus of the protein (res-
idues 1–15) with maximal sequence divergence compared
with other VAMPs. Anti-VAMP4 inhibited EE/RE-to-
TGN transport in a dose dependent manner, and inhibition
was lost when the antibody was prebound to its antigen (Fig.
4 A). We furthermore observed that purified VAMP4-cyto
inhibited STxB transport to the TGN on permeabilized
HeLa cells, whereas VAMP8-cyto had no effect (Fig. 4 A).
As shown for Syn6 and Syn16 (Fig. 2 G), overexpression of
VAMP4-cyto also inhibited TGN38 cycling to the TGN,
whereas VAMP7-cyto was without effect (Fig. 4 B). Thus,
VAMP4 function was necessary not only for retrograde
transport of STxB, but also for that of TGN38.
VAMP4 and Syn16 appeared to interact physically and
functionally. Indeed, antibodies against Syn16 and VAMP4,
when combined, had no additive inhibitory effects (Fig. 4
C), suggesting that these two molecules functioned in the
same molecular complex, as described above for Syn6 and
Syn16 (Fig. 2, E–F).
Our anti-peptide antibody against the NH
 
2
 
 terminus of
VAMP3/cellubrevin was without effect, even at high concen-
trations (unpublished data). Because it has been reported that
VAMP3/cellubrevin is cleaved by tetanus neurotoxin (TeNT)
(Galli et al., 1994), we tested whether TeNT would modulate
transport. As shown in Fig. 5 A, TeNT cleaved VAMP3/cel-
lubrevin (Galli et al., 1994), but not VAMP7/TI-VAMP
(Galli et al., 1998), VAMP4, or VAMP8/endobrevin. Fur-
thermore, an antibody that recognizes all synaptobrevin-like
and TeNT-sensitive VAMPs (clone 10.1) (McMahon et al.,
1993) revealed that VAMP3/cellubrevin was the only mem-
ber of this group to be expressed in HeLa cells (Fig. 5 B). At
TeNT concentrations above 100 nM, a condition under
which most VAMP3/cellubrevin was degraded (Fig. 5 A), EE/
RE-to-TGN transport was inhibited by 25%, whereas an in-
active mutant of TeNT, TeNT (E234Q), was without effect
(Fig. 5 C). As a whole, these data suggest that the TeNT effect
was due to modulation of VAMP3/cellubrevin activity.
Importantly, when TeNT and anti-VAMP4 antibody
were added together, transport inhibition was additive (Fig.
5 D). This observation is consistent with the above-men-
tioned hypothesis that both v-SNAREs interact indepen-
dently with the Syn6/Syn16/Vti1a t-SNAREs (Fig. 3). The
level of residual transport (Fig. 5 D) was comparable to that
observed in the presence of anti-Syn6, anti-Syn16, or anti-
Vti1a antibodies (Fig. 3 B), again confirming that these mol-
ecules act in the same transport step.
To further investigate the potential role of VAMP3/cellu-
brevin and VAMP4 in EE/RE-to-TGN transport, the distri-
bution of both proteins was compared with that of STxB in-
ternalized at low temperatures into the EE (Fig. 6). Many of
the STxB containing early endosomal structures were also la-
beled with VAMP3/cellubrevin. Using anti-VAMP4 (un-
published data) or GFP-coupled VAMP4 (Fig. 6), similar
observations were made.
 
The role of Rab6a
 
 
 
 in EE/RE-to-TGN transport
 
The addition of the nonhydrolyzable GTP-analogue GTP
 
 
 
S
to the permeabilized cell assay resulted in a strong inhibition
of EE/RE-to-TGN transport (Fig. 7 A), implicating a func-
tion for GTPases. We further showed the involvement of
proteins of the Rab family of small GTPases (Zerial and
Figure 6. VAMP3/cellubrevin and 
GFP-VAMP4 colocalized with STxB on 
membranes of EE/RE. Cy3-labeled STxB 
was internalized at low temperatures 
into EE/RE of untransfected (VAMP3) or 
GFP-VAMP4–transfected HeLa cells. 
The cells were then fixed and stained 
with anti-VAMP3, where indicated. A 
subset of STxB containing structures 
were also labeled for VAMP3/cellubrevin 
or VAMP4. 
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McBride, 2001), as their removal from membranes by prein-
cubation of SLO-permeabilized cells with recombinant Rab-
GDI (GDP-dissociation inhibitor) resulted in a strong inhibition
of transport (Fig. 7 A). An antibody against Golgi-localized
Rab6 potently inhibited EE/RE-to-TGN transport (Fig. 7 B).
The inhibition obtained with the anti-Rab6 antibody was
markedly stronger than that observed with an antibody to
Rab11 (Fig. 7 C), which we had previously implicated in the
regulation of membrane dynamics at the RE-TGN interface
(Wilcke et al., 2000). The combined use of both antibodies
did not lead to a significant increase in inhibition (Fig. 7 C).
Recently it has become clear that mammalian cells express
two Rab6 isoforms, termed Rab6a and Rab6a
 
 
 
 (Echard et al.,
2000). Rab6a and Rab6a
 
 
 
 differ in only three amino-acids,
and available anti-Rab6 antibodies recognize both proteins
equally well (Echard et al., 2000). To discriminate between
Rab6a and Rab6a
 
 
 
 function, mutants were overexpressed in
HeLa cells (Fig. 8 A). A dominant-negative Rab6a
 
 
 
 mutant
(Rab6a
 
 
 
T27N) was found to be a potent inhibitor of EE/RE-
to-TGN transport, as measured by the sulfation assay (Fig. 8
A) or immunofluorescence analysis in transfected cells (Fig. 8
C). In cells overexpressing Rab6a
 
 
 
T27N, STxB accumulated
in transferrin receptor containing EE/RE (Fig. 8 D). In con-
trast, the GTPase deficient mutant Rab6a
 
 
 
Q72L only weakly
affected transport (Fig. 8 A), an effect that probably coin-
cided with a mild alteration of Golgi morphology (Fig. 8 C).
These findings thus suggested that Rab6a
 
 
 
 regulates retro-
grade transport to the TGN.
On the other hand, both Rab6aT27N and Rab6aQ72L in-
hibited transport by 
 
 
 
50% (Fig. 8 A). The block induced
by Rab6aQ72L was actually expected, as this mutant
causes redistribution of Golgi membranes (Martinez et
al.,  1997) including the TGN-localized t-SNAREs Syn6,
Syn16, and Vti1a (unpublished data). The inhibitory effect
of Rab6aT27N, although less pronounced than that of
Rab6a
 
 
 
T27N, was more surprising in the light of its function
in Golgi-to-ER transport (Martinez et al., 1997). However, it
should be pointed out that all Rab6-binding proteins identi-
fied so far interact with both Rab6a and Rab6a
 
 
 
. The only no-
ticeable exception is the Rab6a interacting protein Rabkine-
sin-6 (Echard et al., 2000), a molecular motor likely to be
involved in the long-range movement of Rab6a positive struc-
tures between the Golgi and the ER (Echard et al., 1998;
White et al., 1999). Therefore, overexpression of Rab6aT27N
might titrate molecules required for Rab6a
 
 
 
 function, result-
ing in an indirect inhibition of EE/RE-to-TGN transport.
All Rab6 mutants that were used in this study were ex-
pressed to similar levels (Fig. 8 B). The specificity of our ob-
servations is illustrated by the fact that overexpression under
identical conditions as those described above of a dominant
negative Rab4 mutant did not affect post-Golgi retrograde
transport (unpublished data). Furthermore, recently pub-
lished data suggests that dominant negative Rab5 does not in-
terfere with STxB transport to the Golgi apparatus (Nichols et
al., 2001). In view of the potent and specific inhibition of ret-
rograde transport by Rab6a
 
 
 
T27N, we therefore conclude
that Rab6a
 
 
 
 function is required in this transport step.
 
Discussion
 
STxB and TGN38 are both transported from EE/RE di-
rectly to the TGN (Ghosh et al., 1998; Mallard et al.,
1998), bypassing the late endocytic pathway taken by
mannose 6-phosphate receptors (Lombardi et al., 1993).
Through this direct pathway, both proteins efficiently es-
cape the route to lysosomes. Furthermore, STxB only mar-
ginally recycles (Mallard et al., 1998), raising the question of
the molecular mechanisms that are responsible for its effi-
cient transport to the TGN. To address this question, we re-
constituted STxB transport from EE/RE to the TGN in
SLO-permeabilized HeLa cells. Transport in permeabilized
cells conserved the hallmarks of transport in intact cells.
First, it occurred with comparable kinetics in intact and per-
meabilized cells and was cytosol- and energy-dependent, as
expected for a classical vesicular transport process. Second,
we could show by electron microscopy that in permeabilized
cells, STxB accumulated in a cytosol-dependent manner in
TGN46- and GalT-positive Golgi compartments, as in in-
tact cells. Third, modulating the activity of specific syntax-
ins, VAMP and Rab proteins had the same effects on EE/
RE-to-TGN transport in both, permeabilized and intact
cells. Taken together, these data indicate that EE/RE-to-
TGN transport is efficiently reconstituted in SLO-perme-
abilized HeLa cells.
 
Specific SNAREs regulate EE/RE-to-TGN transport
 
In recent years, it has become clear that SNARE proteins are
key regulators of membrane fusion (Rothman and Wieland,
Figure 7. The Rab6 and Rab11 regulate EE/RE-to-TGN transport. (A) Permeabilized HeLa cells were incubated either continuously with 
GTP S (1 mM), or pretreated with the indicated concentrations of recombinant Rab-GDI. (B) The indicated concentrations of anti-Rab6 
antibody or control rabbit IgG (0.1 mg/ml) were continuously present from permeabilization on. (C) Anti-Rab6 (75  g/ml) and anti-Rab11 
(100  g/ml) antibodies did not have additive inhibitory effects when added at the same time to the permeabilized cell assay. 
Mechanisms of EE/RE-to-TGN transport |
 
 Mallard et al. 661
 
1996; Hay and Scheller, 1997; Johannes and Galli, 1998).
As each SNARE has a precise subcellular distribution, it has
been suggested that selective interactions between SNAREs
contribute to the specificity of membrane exchanges be-
tween intracellular compartments. This concept has recently
been further documented by in vitro (McNew et al., 2000)
and permeabilized cell (Scales et al., 2000) studies. Our data
is in accordance with this concept of specific SNARE inter-
actions. In fact, we show by coimmunoprecipitation that
Syn16 interacts with Syn6 and Vti1a, but not Syn5, Syn7,
Syn12, or Vti1b, and Syn6/Syn16/Vti1a interacts with
VAMP3/cellubrevin and VAMP4, but not with VAMP7/
TI-VAMP or VAMP8/endobrevin.
In agreement with the interaction studies, we found
that EE/RE-to-TGN transport depends on two endosomal
v-SNAREs. Indeed, anti-VAMP4 antibody and TeNT, which
does not cleave VAMP4, both inhibited STxB and TGN38
transport to the TGN. The only TeNT-sensitive v-SNARE
 
that we could detect in HeLa cells was VAMP3/cellubre-
vin, thus identifying this protein as a second candidate
v-SNARE. Importantly, TeNT and anti-VAMP4 antibody
had additive inhibitory effects, supporting the function of
these v-SNAREs in separate molecular complexes. This con-
clusion is given further credence by the observation that
VAMP3/cellubrevin did not coimmunoprecipitate with
VAMP4, and vice versa.
The above-mentioned interaction data also suggests the
formation of a specific t-SNARE complex between Syn6,
Syn16, and Vti1a, and we indeed observed that Syn6, but
not Syn5, stimulated binding of Syn16 to GST-VAMP4
(unpublished data). However, due to the low solubility
of Syn16, binding was inefficient and final evidence for
the existence of a stable and functional Syn6/Syn16/Vti1a
t-SNARE complex will require in vitro fusion studies with
VAMP3/cellubrevin and VAMP4 containing liposomes, as
described by McNew and colleagues (2000).
Figure 8. Specific role of the Rab6a’ isoform in EE/RE-to-TGN transport. (A) Sulfation analysis on intact cells overexpressing the indicated 
Rab6a and Rab6a  mutants or a dominant negative Rab11 mutant. Note that dominant negative Rab6a T27N strongly inhibited retrograde 
transport to the TGN. (B) Western blot analysis of the expression levels of the indicated Rab6 mutants. All mutants were equally well expressed. 
CTL, empty vector transfected cells. (C) Cy3-labeled STxB was internalized for 45 min at 37 C into cells expressing the indicated proteins. 
The cells were then fixed and stained with antibodies to the medial Golgi marker CTR433 or Rab6. (D) In Rab6a T27N–expressing cells, STxB 
(red) accumulated in transferrin receptor (TfR, green) containing EE/RE. 
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In this context it appears noteworthy that Syn6 is not only
found on the TGN, but also on the EE (Bock et al., 1996,
1997), and the protein interacts with a number of early endo-
somal v-SNAREs, such as VAMP3/cellubrevin (Bock et al.,
1997), VAMP4 (Steegmaier et al., 1999), and VAMP8/endo-
brevin (this study). Furthermore, Syn6 is the most distant
member of the syntaxin family, and its sequence is similar to
the SN2 domain of SNAP23/25/29, much as Vti1a is similar
to the SN1 domain (Bock et al., 2001). Therefore, it appears
likely that Syn6 and Vti1a may serve as light chains of
t-SNARE complexes with a more general function at the EE/
RE-TGN interface (Bock et al., 2001). In contrast, Syn16 lo-
calization on the TGN appears to be very restrictive (this
study), suggesting that this molecule is of primary importance
for the definition of specificity in EE/RE-to-TGN transport.
The yeast SNARE proteins Tlg1p and Tlg2p show se-
quence similarity with Syn6 and Syn16, respectively. Con-
flicting results have been obtained on the function(s) of
these proteins. They have been implicated in several path-
ways, such as cytosol-to-vacuole (Tlg2p) (Abeliovich et al.,
1999), EE-to-TGN (Tlg1p and Tlg2p) (Lewis et al., 2000),
endocytosis (Tlg2p) (Seron et al., 1998), and intra-Golgi
transport (Tlg1p) (Coe et al., 1999). Assuming that Tlg1p
and Tlg2p are in fact functional homologues of Syn6 and
Syn16, respectively, our results establish their role in EE/
RE-to-TGN transport. Indeed, in addition to the approach
of expression of dominant negative mutants in whole cells,
we have also used a permeabilized cell approach that allows
the reconstitution of the key retrograde transport steps
within the complex array of post-Golgi traffic. Similarly, the
role of Vti1 proteins in yeast (Lupashin et al., 1997; Fischer
von Mollard and Stevens, 1999; Ungermann et al., 1999;
Sato et al., 2000), plants (Zheng et al., 1999), and mammals
(Xu et al., 1998) has remained a matter of debate, particu-
larly in the light of their multiple interactions with other
SNAREs. Using in vitro assays, the mammalian Vti1b was
found to function in homotypic fusion of late endosomes,
and Vti1a in that of the early endosome (Antonin et al.,
2000). In conjunction with our data, the latter observation
indicates a more generalized role for Vti1a in membrane fu-
sion on the EE.
 
A Rab6 isoform regulates EE/RE-to-TGN transport
 
In addition to the previously suggested role of Rab11 in EE/
RE-to-TGN transport (Wilcke et al., 2000), we have now
provided evidence that another Rab protein, Rab6, is involved
in this transport step. Lower eukaryotes, such as the yeast 
 
Sac-
charomyces cerevisiae
 
 and the parasite 
 
Plasmodium falciparum
 
express only one Rab6 protein (Echard et al., 2000). In mam-
malian cells, an exon duplication within the 
 
Rab6a
 
 gene has
given rise to two different isoforms, Rab6a and Rab6a
 
 
 
, of
which the latter appears to represent the ancestral form of
Rab6 (Echard et al., 2000). In agreement with the hypothesis
that Ypt6p and Rab6a
 
 
 
 are evolutionarily related, we found
here that the Rab6a
 
 
 
 isoform specifically regulates retrograde
transport to the TGN, as suggested for Ypt6p in yeast
(Tsukada and Gallwitz, 1996; Bensen et al., 2001; Sinios-
soglou and Pelham, 2001). Because Ypt6p/Rab6a
 
 
 
 are located
on TGN membranes, their function could be to regulate tar-
geting/docking of EE/RE-derived vesicles with the TGN.
 
Without ruling out that also Rab6a may play a role in
docking of EE/RE-derived vesicles at the TGN, Rab6a was
previously shown to function in Golgi-to-ER retrograde
transport (Martinez et al., 1997; Girod et al., 1999; White
et al., 1999). It appears therefore that in mammalian cells,
two isoforms of the same Rab protein control successive
steps in retrograde transport. In addition, through an inter-
action with Rabkinesin-6 (Echard et al., 2000), Rab6a may
participate in the coordination between retrograde mem-
brane transport and progression through the cell cycle (Hill
et al., 2000; Fontijn et al., 2001).
 
The complexity of the EE/RE-to-Golgi retrograde 
transport route in mammalian cells
 
The fact that EE/RE-to-TGN transport is regulated by spe-
cific SNAREs and Rab proteins suggests that it is a physio-
logical, preexisting cellular pathway. The question arises as
to whether transport from the EE, which is accessible during
low temperature incubations used as a starting point in this
study, to the TGN necessarily transits via the RE. That such
a passage exists appears likely considering the accumulation
of TGN38 (Ghosh et al., 1998) and STxB (Mallard et al.,
1998) in the RE. Furthermore, modulating the activity of
Rab11, a marker of the RE (Sheff et al., 1999), affects post-
Golgi retrograde transport to the TGN (this study and
Wilcke et al., 2000). However, both in permeabilized and
intact cells, the Rab11 effect is weak as compared with the
modulation of Rab6a
 
 
 
 activity. One interpretation of this data
is that both GTPases act on two sequential steps of retrograde
transport to the TGN, a hypothesis that is in agreement with
the observation that modulating the activities of Rab6 and
Rab11 in the same system does not result in additive inhibi-
tion of retrograde transport. Rab6a
 
 
 
 would also control an ad-
ditional, Rab11-independent transport reaction to the TGN.
VAMP3/cellubrevin- and VAMP4-dependent transport inhi-
bition is additive, but not complete. Whether this reflects
technical limitations or a high degree of versatility in mem-
brane exchange between the early endocytic pathway and the
TGN, as reported by Lippincott-Schwartz and colleagues
(Nichols et al., 2001), remains to be determined.
In this study, we have provided the first molecular dissec-
tion of the EE/RE-to-TGN retrograde transport step in mam-
malian cells. The observed transport may correspond to the
one required in 
 
S. cerevisiae
 
 for proper localization and/or re-
cycling of TGN proteins. Indeed, the same molecules appear
to be involved: Rab6a
 
 
 
 may be the functional homologue of
Ypt6p, and Tlg1p and Tlg2p, recently found to interact with
Ypt6p via the Vps52/53/54p complex (Siniossoglou and Pel-
ham, 2001), show sequence similarity with Syn6 and Syn16,
respectively. However, the fact that in the mammalian system
two v-SNAREs appear to functionally interact with the same
t-SNAREs suggests that EE/RE-to-TGN transport has gained
in complexity during evolution, with the appearance of the
RE and the involvement of Rab11 in higher eucaryotes.
 
Materials and methods
 
Recombinant proteins, antibodies, other reagents and media
 
TeNT and TeNT(E234Q) light chains (Galli et al., 1994), (His)
 
6
 
-
 
 
 
-SNAP,
(His)
 
6
 
-
 
 
 
-SNAP(L294A) (Barnard et al., 1997), and STxB-Sulf
 
2
 
 (Mallard et al.,
1998), were obtained as described. Polyclonal antibodies against the cytoso- 
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lic domains of Syn6, Syn7, Syn10, Syn16, and Vti1a, or the first 15 amino ac-
ids of human VAMP4 were produced in rabbits. Control rabbit IgG (Sigma-
Aldrich), monoclonal anti-Syn6, anti-Vti1a, anti-Vti1b antibodies (Transduc-
tion Laboratories), SLO, a gift of Dr. S. Bhakdi (Johannes-Gutenberg-Universität,
Mainz, Germany), and radioactive sulfate (Amersham Pharmacia Biotech)
were purchased. HBSS and MEM without sulfate (Johannes et al., 1997) and
radiolabeled [
 
35
 
S]-PAPS (Itin et al., 1997) were prepared as described. ATP
regenerating system was made of 1 mM ATP, 0.2 mM GTP (omitted where
indicated), 50 
 
 
 
M UTP (Boehringer), 5 mM creatine phosphate and 15 
 
 
 
g/ml
creatine phosphokinase (Sigma-Aldrich) in 10 mM Hepes, pH 7.2.
 
HeLa S3 cytosol
 
6 
 
 
 
 10
 
9
 
 HeLa S3 cells were resuspended in 20 ml (final volume) ice-cold
HK buffer (90 mM KCl, 50 mM Hepes, pH 7.2) supplemented with pro-
tease inhibitor cocktail. Cells were then homogenized in a potter. The su-
pernatant of low-speed (10 min, 6,000 
 
g
 
, 4
 
 
 
C) and high-speed centrifuga-
tion (45 min, 10
 
5
 
 
 
g
 
, 4
 
 
 
C) was dialyzed against ICT/DTT buffer (78 mM KCl,
4 mM MgCl
 
2
 
, 8.4 mM CaCl
 
2
 
, 10 mM EGTA, 1 mM DTT, 50 mM Hepes,
pH 7.2). Protein concentration was around 10 mg/ml.
 
Immunofluorescence, immunoelectron microscopy, and immunoprecipita-
tion. 
 
Immunofluorescence and immuno-EM were performed essentially as
described (Johannes et al., 1997). Coimmunoprecipitations: NRK or HeLa
cells were lysed in 50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100,
0.1 mM PMSF and a protease inhibitor cocktail, and lysates were incubated
with affinity-purified antibodies and protein A-Sepharose beads or IgG-cou-
pled Dynabeads (Dynal). Immunoprecipitates were tested by Western blot-
ting for the indicated proteins. In some cases, cells on ice were treated with
either 1 mM NEM for 15 min followed by 15 min with 2 mM DTT, or for 30
min with 1 mM NEM quenched with 2 mM DTT, followed by incubated for
30 min at 37
 
 
 
C before lysis and immunoprecipitation. 
 
STxB transport assay in SLO-permeabilized HeLa cells. 
 
10
 
5
 
 HeLa cells
were incubated for 90 min in MEM without sulfate at 37
 
 
 
C and for 45 min
at 19.5
 
 
 
C in the presence of 1 
 
 
 
M STxB-Sulf
 
2
 
. Cells were then placed on ice
and incubated for 10 min in the presence of 1 
 
 
 
g/ml of SLO in ICT/DTT.
Unbound SLO was removed by washes and cells were transferred to 37°C
for 10 min in ICT/DTT. Transport of STxB-Sulf
 
2
 
 to the TGN was assayed by
incubating the permeabilized cells for 30 min at 37
 
 
 
C in the presence of cy-
tosol mix (3 mg/ml cytosol and ATP regenerating system in ICT/DTT, except
when otherwise stated), supplemented with 1 
 
 
 
Ci/ml [
 
35
 
S]sulfate (or 10 
 
 
 
Ci/
ml [
 
35
 
S]-PAPS where indicated). After incubation, the cells were lysed in 1
ml RIPA buffer containing a protease inhibitor cocktail and subjected to
quantitative immunoprecipitation with 13C4 antibody. Immunoprecipitated
STxB-Sulf
 
2
 
 was separated from radioactive contaminants by migration on a
Tris-Tricine gel, and the amount of sulfated STxB-Sulf
 
2
 
 for each condition
was quantified using a PhosphorImager and the ImageQuant software (Mo-
lecular Dynamics). Sulfation of endogenous proteins and proteoglycans was
quantified by scintillation counting of TCA-precipitable material. The corre-
sponding results were used to normalize the amount of sulfated STxB-Sulf
 
2
 
for each condition. Only experiments were included where endogenous
sulfation was within a 10% range in all conditions.
Antibodies were added from the permeabilization step on, whereas re-
combinant (His)
 
6
 
-
 
 
 
-SNAP or (His)
 
6
 
-
 
 
 
-SNAP(L294A) were only added to the
transport mix. For GDI or TeNT treatment, SLO-permeabilized cells were
incubated at 37
 
 
 
C for 15 min in the presence of, respectively, 1 
 
 
 
M GDI
 
 
 
,
100 nM TeNT or TeNT(E234Q).
 
STxB retrograde transport assay on intact cells
 
The indicated Rab proteins or cytosolic domains of syntaxins (residues 1–234
of Syn6, residues 1–237 of Syn7, and residues 1–284 of Syn16) were overex-
pressed for, respectively, 6 or 10 h in intact cells using the vaccinia virus ex-
pression system, as described (Martinez et al., 1997). Transfection efficiencies
were routinely 
 
 
 
70% in all conditions. Cy3-coupled STxB and STxB-Sulf
 
2
 
transport to the TGN was assayed as described (Mallard et al., 1998). After
STxB-Sulf
 
2
 
 binding, HeLa cells were incubated for 20 min in the presence of
radioactive sulfate, followed by immunoprecipitation and gel electrophoresis.
 
Anti-Tac uptake experiments
 
CHO cells expressing a chimeric TGN38 protein with an extracellular Tac
domain (Ghosh et al., 1998) were transfected with expression constructs
for the cytoplasmic domains of Syn6, Syn7 or Syn16. 24 h after transfec-
tion, the cells were incubated for 1 h with culture supernatant containing
Tac monoclonal IgGs, washed extensively, fixed and labeled with the indi-
cated antibodies.
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